Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AGIOS PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 106,996 shares of AGIO (AGIOS PHARMACEUTICALS INC), worth $2.9M as of 2025-Q4. The position was increased (++0.1% shares). AGIO represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.9M
Current Shares
106,996
Total Value Change
-$2.5M
Total Shares Change
-18,474
Other major holders of AGIO: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 106,996 |
+0.1% |
| $2.9M |
| 0.0% |
| $27.33 |
26 |
| 2025-Q3 | Decreased | 106,875 | -50.8% | $4.3M | 0.0% | $39.27 | 0 |
| 2025-Q2 | Increased | 217,402 | +47.6% | $7.2M | 0.0% | $33.47 | 37 |
| 2025-Q1 | Increased | 147,276 | +19.9% | $4.3M | 0.0% | $30.28 | 32 |
| 2024-Q4 | Increased | 122,835 | +8.5% | $4M | 0.0% | $33.03 | 29 |
| 2024-Q3 | Decreased | 113,229 | -9.8% | $5M | 0.0% | $45.61 | 0 |
| 2024-Q2 | Increased | 125,470 | +164.4% | $5.4M | 0.0% | $43.12 | 44 |